Takeda Pharmaceutical Co Ltd
TAK
Closed
$18.18
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Key stats
Open
$18.05
Volume
1.48M
Market cap
$58.48B
Prev. close
$18.18
Impl / hst vl
-
Open interest
$0.00
$18.05
Day’s Range
$18.24
$14.84
52W Range
$18.90
Valuation
55
Valuation score
Fairly Valued
P/E
-
P/S
1.92
P/B
1.17
Current ratio
1.14
Debt / Equity
0.65
ROE
-2.20%
Gross margin
66.66%
Income growth
-130.72%
FCF growth
116.99
Dec
1
Dividends
The next payment date will be Dec 1, 2026
Div. per Share
$0.64
Div. Yield
561.06%
Payout Ratio
-
Div. Growth YoY
0.01%
Analysts estimates
Consensus rating
Buy
The average rating from top 9 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$20.57
The top 18 analysts forecasts that 12-month price may increase by 13.12%, with a low of $17.24 and a high of $26.21
$17.24
Low
$20.57
Avg
$26.21
High
Current price
Earnings
Q2 ‘26 revenue
$7.67B
Q2 ‘26 net income
$712.02M
Revenue
Net income
Previous EPS
-$0.05
Estimate EPS
$0.22
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply